Tenon Medical, Inc. (TNONW) stock
TNONWNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as TNON
$0.00−0.00 (-36.17%)
Close on Oct 30, 2026Market cap $1.37MP/E –Yield –
Tenon Medical r&d expenses
Research and development expenses are spending on new products and technology.
Tenon Medical's R&D Expenses for the twelve months ending Jun 30, 2026 was $2.39M, down 1.4% year over year. For fiscal 2025 it was $2.15M, down 17.4% from the year before. The highest annual figure on record is $3.16M in fiscal 2023.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.15M | -17.4% |
| FY2024 | Dec 31, 2024 | $2.60M | -17.7% |
| FY2023 | Dec 31, 2023 | $3.16M | +11.8% |
| FY2022 | Dec 31, 2022 | $2.83M | +64.6% |
| FY2021 | Dec 31, 2021 | $1.72M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $768.00K | +52.7% |
| Q1 FY2026 | Mar 31, 2026 | $662.00K | -4.2% |
| Q4 FY2025 | Dec 31, 2025 | $527.00K | -7.4% |
| Q3 FY2025 | Sep 30, 2025 | $428.00K | -34.9% |
| Q2 FY2025 | Jun 30, 2025 | $503.00K | -29.0% |
| Q1 FY2025 | Mar 31, 2025 | $691.00K | +3.3% |
| Q4 FY2024 | Dec 31, 2024 | $569.00K | -17.7% |
| Q3 FY2024 | Sep 30, 2024 | $657.00K | -21.2% |
| Q2 FY2024 | Jun 30, 2024 | $708.00K | -12.8% |
| Q1 FY2024 | Mar 31, 2024 | $669.00K | -16.1% |
| Q4 FY2023 | Dec 31, 2023 | $691.00K | +5.2% |
| Q1 FY2023 | Mar 31, 2023 | $834.00K | +48.4% |
| Q4 FY2022 | Dec 31, 2022 | $812.00K | +2.4% |
| Q3 FY2022 | Sep 30, 2022 | $797.00K | +32.6% |
| Q2 FY2022 | Jun 30, 2022 | $657.00K | +177.2% |
| Q1 FY2022 | Mar 31, 2022 | $562.00K | +546.0% |
| Q4 FY2021 | Dec 31, 2021 | $793.00K | – |
| Q3 FY2021 | Sep 30, 2021 | $601.00K | – |
| Q2 FY2021 | Jun 30, 2021 | $237.00K | – |
| Q1 FY2021 | Mar 31, 2021 | $87.00K | – |